Market Cap 2.31B
Revenue (ttm) 427.54M
Net Income (ttm) -21.02M
EPS (ttm) N/A
PE Ratio 216.89
Forward PE N/A
Profit Margin -4.92%
Debt to Equity Ratio 0.40
Volume 389,500
Avg Vol 880,882
Day's Range N/A - N/A
Shares Out 29.82M
Stochastic %K 58%
Beta 1.92
Analysts Strong Sell
Price Target $89.44

Company Profile

GeneDx Holdings Corp., a genomics company, provides genetic testing services. The company primarily offers pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing, as well as data and information services. It also develops an AI-based platform for next generation sequencing analysis, interpretation, and clinical reporting for rare disease, hereditary risk, and cancer testing. GeneDx Holdings Corp. was founded in 2000 and is headquartered in Stamford, Connecticut.

Industry: Diagnostics & Research
Sector: Healthcare
Phone: 888 729 1206
Fax: 201 421 2010
Address:
North Tower, 6th Floor 333 Ludlow Street, Stamford, United States
Grouphome
Grouphome Aug. 13 at 1:46 PM
$WGS closed, will revisit
0 · Reply
11thestate
11thestate Aug. 13 at 1:09 PM
Everything you need to know about the $21M $WGS Settlement Payout Q: What happened? A: CM Life Sciences, which later became Sema4 and now operates as GeneDx Holdings, agreed to a $21 million settlement over claims that shareholders were misled during the 2021 de-SPAC merger and were not given enough information to make an informed decision about redeeming their shares. The settlement was approved by the Delaware Court of Chancery. Q: Am I actually eligible? A: If you held CM Life shares in 2021, you may be eligible. You don't need to hold the stock today; the settlement covers eligible shareholders from the merger period. Q: When do payouts happen? A: Typically, payouts take around 4–9 months after the claim deadline, but the exact timing depends on the settlement administration. Q: I missed the deadline. Is it too late? A: No, you may still be able to file a late claim, but acceptance depends on final approval by the court. Check if you're eligible and file a claim: https://11th.com/cases/cmls-investor-settlement
0 · Reply
BB_88_
BB_88_ Aug. 12 at 7:30 PM
$WGS Dangitt should have held
1 · Reply
CarverX
CarverX Aug. 12 at 7:25 PM
$TEM Tired of slipping. Come on over to $WGS 🚀🚀🚀
0 · Reply
CarverX
CarverX Aug. 12 at 7:23 PM
$WGS Like a dragonfly skating at the surface🚀🚀🚀
0 · Reply
CarverX
CarverX Aug. 12 at 6:07 PM
$WGS Dojis and engulfing candles, can we make it 6 days of green? 50 day is moving towards the 100 day and technicals are looking good. Not a lot of resistance in the 80s. If you are shorting now, you are on the wrong side of the trade IMO 🚀🚀🚀
0 · Reply
CarverX
CarverX Aug. 11 at 6:29 PM
$WGS Shorts running for cover 🚀🚀🚀
0 · Reply
MaverikIT
MaverikIT Aug. 11 at 6:11 PM
$WGS +4.58 - nice conf reaction$
0 · Reply
CarverX
CarverX Aug. 11 at 4:27 PM
$WGS pushed through 200 day EMA, don’t see a lot of resistance in the 80s. 84 is the next Fibonacci retracement 🚀🚀🚀
1 · Reply
Grouphome
Grouphome Aug. 11 at 3:04 PM
$WGS sweeet
0 · Reply
Latest News on WGS
GeneDx to Participate in Upcoming Investor Conferences

Aug 6, 2026, 4:05 PM EDT - 12 days ago

GeneDx to Participate in Upcoming Investor Conferences

WGS


GeneDx Holdings Earnings Call Transcript: Q2 2026

Aug 3, 2026, 4:30 PM EDT - 15 days ago

GeneDx Holdings Earnings Call Transcript: Q2 2026


GeneDx Holdings Slides: Q2 2026

Aug 3, 2026, 4:30 PM EDT - 15 days ago

GeneDx Holdings Slides: Q2 2026


GeneDx Holdings Earnings release: Q2 2026

Aug 3, 2026, 4:30 PM EDT - 15 days ago

GeneDx Holdings Earnings release: Q2 2026


GeneDx Holdings Quarterly report: Q2 2026

Aug 3, 2026, 4:30 PM EDT - 15 days ago

GeneDx Holdings Quarterly report: Q2 2026


GeneDx Reports Second Quarter 2026 Financial Results

Aug 3, 2026, 4:05 PM EDT - 15 days ago

GeneDx Reports Second Quarter 2026 Financial Results

WGS


GeneDx Holdings Transcript: AGM 2026

Jun 18, 2026, 9:00 AM EDT - 2 months ago

GeneDx Holdings Transcript: AGM 2026


GeneDx Holdings Earnings Call Transcript: Q1 2026

May 4, 2026, 4:30 PM EDT - 3 months ago

GeneDx Holdings Earnings Call Transcript: Q1 2026


GeneDx Holdings Slides: Q1 2026

May 4, 2026, 4:30 PM EDT - 3 months ago

GeneDx Holdings Slides: Q1 2026


GeneDx Holdings Earnings release: Q1 2026

May 4, 2026, 4:30 PM EDT - 3 months ago

GeneDx Holdings Earnings release: Q1 2026


GeneDx Holdings Quarterly report: Q1 2026

May 4, 2026, 4:30 PM EDT - 3 months ago

GeneDx Holdings Quarterly report: Q1 2026


GeneDx Holdings Proxy statement: Proxy filing

Apr 30, 2026, 8:00 AM EDT - 3 months ago

GeneDx Holdings Proxy statement: Proxy filing


GeneDx Holdings Proxy statement: Proxy filing

Apr 30, 2026, 8:00 AM EDT - 3 months ago

GeneDx Holdings Proxy statement: Proxy filing


GeneDx Holdings Earnings Call Transcript: Q4 2025

Feb 23, 2026, 8:30 AM EST - 6 months ago

GeneDx Holdings Earnings Call Transcript: Q4 2025


GeneDx Holdings Annual report: Q4 2025

Feb 23, 2026, 8:30 AM EST - 6 months ago

GeneDx Holdings Annual report: Q4 2025


GeneDx Holdings Earnings release: Q4 2025

Feb 23, 2026, 8:30 AM EST - 6 months ago

GeneDx Holdings Earnings release: Q4 2025


GeneDx Holdings Slides: Q4 2025

Feb 23, 2026, 8:30 AM EST - 6 months ago

GeneDx Holdings Slides: Q4 2025


Why is GeneDx stock crashing on Monday?

Jan 12, 2026, 3:03 PM EST - 7 months ago

Why is GeneDx stock crashing on Monday?

WGS


Grouphome
Grouphome Aug. 13 at 1:46 PM
$WGS closed, will revisit
0 · Reply
11thestate
11thestate Aug. 13 at 1:09 PM
Everything you need to know about the $21M $WGS Settlement Payout Q: What happened? A: CM Life Sciences, which later became Sema4 and now operates as GeneDx Holdings, agreed to a $21 million settlement over claims that shareholders were misled during the 2021 de-SPAC merger and were not given enough information to make an informed decision about redeeming their shares. The settlement was approved by the Delaware Court of Chancery. Q: Am I actually eligible? A: If you held CM Life shares in 2021, you may be eligible. You don't need to hold the stock today; the settlement covers eligible shareholders from the merger period. Q: When do payouts happen? A: Typically, payouts take around 4–9 months after the claim deadline, but the exact timing depends on the settlement administration. Q: I missed the deadline. Is it too late? A: No, you may still be able to file a late claim, but acceptance depends on final approval by the court. Check if you're eligible and file a claim: https://11th.com/cases/cmls-investor-settlement
0 · Reply
BB_88_
BB_88_ Aug. 12 at 7:30 PM
$WGS Dangitt should have held
1 · Reply
CarverX
CarverX Aug. 12 at 7:25 PM
$TEM Tired of slipping. Come on over to $WGS 🚀🚀🚀
0 · Reply
CarverX
CarverX Aug. 12 at 7:23 PM
$WGS Like a dragonfly skating at the surface🚀🚀🚀
0 · Reply
CarverX
CarverX Aug. 12 at 6:07 PM
$WGS Dojis and engulfing candles, can we make it 6 days of green? 50 day is moving towards the 100 day and technicals are looking good. Not a lot of resistance in the 80s. If you are shorting now, you are on the wrong side of the trade IMO 🚀🚀🚀
0 · Reply
CarverX
CarverX Aug. 11 at 6:29 PM
$WGS Shorts running for cover 🚀🚀🚀
0 · Reply
MaverikIT
MaverikIT Aug. 11 at 6:11 PM
$WGS +4.58 - nice conf reaction$
0 · Reply
CarverX
CarverX Aug. 11 at 4:27 PM
$WGS pushed through 200 day EMA, don’t see a lot of resistance in the 80s. 84 is the next Fibonacci retracement 🚀🚀🚀
1 · Reply
Grouphome
Grouphome Aug. 11 at 3:04 PM
$WGS sweeet
0 · Reply
IN0V8
IN0V8 Aug. 10 at 5:56 PM
$WGS Piper Sandler raises target price to $95 from $63
0 · Reply
CarverX
CarverX Aug. 10 at 5:10 PM
$WGS $TEM $GRAL 🚀🚀🚀
0 · Reply
BB_88_
BB_88_ Aug. 10 at 4:54 PM
$WGS short 78.5
1 · Reply
BB_88_
BB_88_ Aug. 10 at 1:44 PM
$WGS short here tight stop
0 · Reply
mattonline1
mattonline1 Aug. 9 at 3:40 PM
$WGS — SELL Revenue growth is strong at 40%+ in recent periods, but the stock already prices in a much cleaner path than the business has earned. Gross margin is still only in the low-50% range, while reimbursement and payer mix can swing realized pricing by 10%+ and pressure cash conversion. The moat is real, with 25M+ tests, 1M+ exomes/genomes, and 8M+ phenotypic datapoints, but that dataset does not eliminate execution risk. A business still dependent on reimbursement outcomes and clinical adoption deserves a discount, not a premium multiple. With valuation elevated versus slower-growing diagnostics peers and free cash flow still not fully proven through a full cycle, downside risk outweighs upside. The setup looks more like a 2-3x revenue story than a durable compounding cash generator. Full research: https://lf0.com/research/genedx-stock-analysis-wgs/
0 · Reply
BB_88_
BB_88_ Aug. 7 at 6:42 PM
$WGS last short didn’t work out had tight stop trying again 76.8s in to close
0 · Reply
BB_88_
BB_88_ Aug. 7 at 5:54 PM
$WGS short here in to close
1 · Reply
CarverX
CarverX Aug. 7 at 4:39 PM
0 · Reply
CarverX
CarverX Aug. 7 at 3:46 PM
$WGS Ready for blast off. Not a lot of resistance in the 80s. 🚀🚀🚀
0 · Reply
CarverX
CarverX Aug. 7 at 3:05 PM
$WGS $NTRA $TEM Natera results lifting genetic diagnostics today 🚀🚀🚀
0 · Reply
CarverX
CarverX Aug. 6 at 10:46 PM
$WGS Stue jealous of $NTRA
0 · Reply
BB_88_
BB_88_ Aug. 6 at 5:05 PM
$WGS short here right stop
1 · Reply